Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(4.19)
# 1,548
Out of 5,096 analysts
1036
Total ratings
54%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: SAN Sanofi | Reiterated: Buy | €95.00 | €80.63 | +17.82% | 149 | Nov 2, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Hold | 11,700p | 13,860p | -15.58% | 200 | Nov 2, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 2,000p | 1,825p | +9.62% | 177 | Nov 2, 2026 | |
| SWX: NOVN Novartis AG | Downgraded: Sell | CHF 120.00 → CHF 115.00 | CHF 131.52 | -12.56% | 143 | Oct 30, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Buy | CHF 500.00 | CHF 397.20 | +25.88% | 145 | Oct 28, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $140 | $87.53 | +59.95% | 33 | Aug 26, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Reiterated: Buy | kr 285.00 → kr 515.00 | kr 479.20 | +7.47% | 18 | Jul 21, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Hold | CHF 70.00 → CHF 65.00 | CHF 82.86 | -21.55% | 9 | Apr 30, 2026 | |
| NVO Novo Nordisk | Downgraded: Hold | n/a | $40.45 | - | 16 | Feb 23, 2026 | |
| ARGX argenx SE | Downgraded: Hold | n/a | $874.97 | n/a | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €11.00 → €12.00 | €11.00 | n/a | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 → €14.00 | €10.74 | n/a | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €22.00 | €28.44 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $45.55 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 1.00 | CHF 4.25 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $220.83 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,410.99 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $4.48 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $8.51 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €95.00 → €124.00 | €155.40 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $60.68 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $54.92 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €44.00 | €52.95 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $123 → $56 | $32.02 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $49.13 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $20.72 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €80.00 | €50.02 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €62.00 → €78.00 | €150.00 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $161.52 | n/a | 4 | Dec 7, 2018 |
Sanofi
Nov 2, 2026
Reiterated: Buy
Price Target: €95.00
Current: €80.63
Upside: +17.82%
AstraZeneca PLC
Nov 2, 2026
Reiterated: Hold
Price Target: 11,700p
Current: 13,860p
Upside: -15.58%
GSK plc
Nov 2, 2026
Reiterated: Hold
Price Target: 2,000p
Current: 1,825p
Upside: +9.62%
Novartis AG
Oct 30, 2026
Downgraded: Sell
Price Target: CHF 120.00 → CHF 115.00
Current: CHF 131.52
Upside: -12.56%
Roche Holding AG
Oct 28, 2026
Reiterated: Buy
Price Target: CHF 500.00
Current: CHF 397.20
Upside: +25.88%
BioNTech SE
Aug 26, 2026
Reiterated: Buy
Price Target: $140
Current: $87.53
Upside: +59.95%
Swedish Orphan Biovitrum AB (publ)
Jul 21, 2026
Reiterated: Buy
Price Target: kr 285.00 → kr 515.00
Current: kr 479.20
Upside: +7.47%
Sandoz Group AG
Apr 30, 2026
Reiterated: Hold
Price Target: CHF 70.00 → CHF 65.00
Current: CHF 82.86
Upside: -21.55%
Novo Nordisk
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $40.45
Upside: -
argenx SE
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $874.97
Upside: n/a
Aug 5, 2025
Reiterated: Hold
Price Target: €11.00 → €12.00
Current: €11.00
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: €12.00 → €14.00
Current: €10.74
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: €22.00
Current: €28.44
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $45.55
Upside: n/a
Nov 29, 2024
Reiterated: Hold
Price Target: CHF 1.00
Current: CHF 4.25
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $220.83
Upside: n/a
Jul 17, 2024
Reiterated: Hold
Price Target: n/a
Current: $1,410.99
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $4.48
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $8.51
Upside: n/a
Aug 7, 2023
Reiterated: Hold
Price Target: €95.00 → €124.00
Current: €155.40
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $60.68
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $54.92
Upside: n/a
Aug 9, 2022
Reiterated: Hold
Price Target: €44.00
Current: €52.95
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $123 → $56
Current: $32.02
Upside: n/a
Apr 16, 2021
Reiterated: Sell
Price Target: n/a
Current: $49.13
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $20.72
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: €80.00
Current: €50.02
Upside: n/a
Jan 15, 2019
Reiterated: Sell
Price Target: €62.00 → €78.00
Current: €150.00
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $161.52
Upside: n/a